The aim of this study is to evaluate the first results in currently introduced kidney transplant center.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Objective: End-stage renal failure is quite common in the community with pronounced morbidity and mortality.
📊
Key Findings & Data:Kidney transplantation is an effective treatment option in patients with renal insufficiency as it improves quality of life and survival.
💡
Conclusion & Impact:The aim of this study is to evaluate the first results in currently introduced kidney transplant center.
Objective: End-stage renal failure is quite common in the community with pronounced morbidity and mortality. Kidney transplantation is an effective treatment option in patients with renal insufficiency as it improves quality of life and survival. The aim of this study is to evaluate the first results in currently introduced kidney transplant center.
Özet
Amaç: Son dönem böbrek yetmezliği belirgin morbidite ve mortalite ile toplumda oldukça yaygındır. Böbrek yetmezliği olan hastalarda, yaşam kalitesini ve sağ kalımı arttırdığı için böbrek nakli etkin bir tedavi seçeneğidir. Bu çalışmanın amacı yeni hizmete giren böbrek nakil merkezindeki ilk sonuçları değerlendirmektir.
Fırat, N., Dheir, H., Akın, E., Sipahi, S., Altıntoprak, F., Çelebi, F., Akçay, M. (2020). Renal Tranplantation in Living Kidney Donors: First Experiences. Online Türk Sağlık Bilimleri Dergisi, Cilt: 5 Sayı: 2, 356–363. https://doi.org/10.26453/otjhs.705092
Arogundade FA, Abd-Essamie MA, Barsoum RS. Health-related quality of life in emotionally related kidney transplantation: deductions from a comparative study. Saudi J Kidney Dis Transpl. 2005;16(3):311-320.
Garcia Garcia G, Harden P, Chapman J. The global role of kidney transplantation. Arab J Nephrol Transplant. 2012;81(5):425-427. doi:10.1097/MOT.0b013e328354c277
Tullius SG, Rabb H. Improving the supply and quality of deceased-donor organs for transplantation. N Engl J Med. 2018;378(20):1920-1929. doi:10.1056/NEJMra1507080
Brown SL, Biehl TR, Rawlins MC, Hefty TR. Laparoscopic live donor nephrectomy: A comparison with the conventional open approach. J Urol. 2001;165(3):766-769. doi:10.1016/S0022-5347(05)66521-4
Flowers JL, Jacobs S, Cho E, et al. Comparison of open and laparoscopic live donor nephrectomy. Ann Surg. 1997;226(4):483-489. doi:10.1097/00000658-199710000-00009
Hiller J, Sroka M, Holochek MJ, Morrison A, Kavoussi LR, Ratner LE. Functional advantages of laparoscopic live-donor nephrectomy compared with conventional open-donor nephrectomy. J Transpl Coord. 1997;7(3):134-140. doi:10.7182/prtr.1.7.3.v503420j4hr31621
Arze Aimaretti L, Arze S. Preemptive Renal Transplantation - The Best Treatment Option for Terminal Chronic Renal Failure. Transplant Proc. 2016;48(2):609-611. doi:10.1016/j.transproceed.2016.02.047
Arogundade FA. Kidney transplantation in a low-resource setting: Nigeria experience. Kidney Int Suppl. 2013;3(2):241-245. doi:10.1038/kisup.2013.23
Tasaki M, Saito K, Nakagawa Y, et al. 20-year analysis of kidney transplantation: A single center in Japan. Transplant Proc. 2014;46(2):437-441. doi:10.1016/j.transproceed.2013.10.052
Kinnunen S, Karhapää P, Juutilainen A, Finne P, Helanterä I. Secular trends in infection-related mortality after kidney transplantation. Clin J Am Soc Nephrol. 2018;13(5):755-762. doi:10.2215/CJN.11511017
Yalci A, Celebi ZK, Ozbas B, et al. Evaluation of Infectious Complications in the First Year after Kidney Transplantation. Transplant Proc. 2015;47(5):1429-1432. doi:10.1016/j.transproceed.2015.04.056
Harris AD, Fleming B, Bromberg JS, et al. Surgical Site Infection after Renal Transplantation. Infect Control Hosp Epidemiol. 2015;36(4):417-423. doi:10.1017/ice.2014.77
Takemoto S, Port FK, Claas FHJ, Duquesnoy RJ. HLA matching for kidney transplantation. Hum Immunol. 2004;65(12):1489-1505. doi:10.1016/j.humimm.2004.06.008
Lim WH, Clayton P, Wong G, et al. Outcomes of kidney transplantation from older living donors. Transplantation. 2013;95(1):106-113. doi: 10.1097/TP.0b013e318277b2be
Noppakun K, Cosio FG, Dean PG, Taler SJ, Wauters R, Grande JP. Living donor age and kidney transplant outcomes. Am J Transplant. 2011;11(6):1279-1286. doi: 10.1111/j.1600-6143.2011.03552.x
Ghafari A. Offspring-to-Mother and Husband-to-Wife Renal Transplantation: A Single-Center Experience. Transplant Proc. 2008;40(1):140-142. doi: 10.1016/j.transproceed.2007.11.062
Calne RY, Thiru S, McMaster P, et al. Cyclosporin a in patients receiving renal allografts from cadaver donors. J Am Soc Nephrol. 1998;9(9):1751-1756. doi: 10.1016/S0140-6736(78)91970-0
Jensik SC. Tacrolimus (FK 506) in kidney transplantation: Three-year survival results of the US Multicenter, randomized, comparative trial. Transplant Proc. 1998;30(4):1216-1218. doi: 10.1016/S0041-1345(98)00216-4
Sollinger HW, Deierhoi MH, Belzer FO, Diethelm AG, Kauffman RS. Rs-61443—a phase i clinical trial and pilot rescue study. Transplantation. 1992;53(2):428-432. doi: 10.1097/00007890-199202010-00031
Dominguez J, Clase CM, Mahalati K, et al. Is routine ureteric stenting needed in kidney transplantation? A randomized trial. Transplantation. 2000;70(4):597-601. doi: 10.1097/00007890-200008270-00011
Sözen H, Özen O, Fidan K, Söylemezoğlu O, Dalgıç A. Outcome of the Double-J Stent Placement in Pediatric Kidney Transplant: A Single Center Experience. Exp Clin Transplant. 2017;1(1):1. doi: 10.6002/ect.2016.0280